Therefore, we speculate that RuvBL1 overexpression might be associated with TRAIL-resistance in NSCLC, and downregulation of RuvBL1 probably sensitizes lung cancer cells to TRAIL-induced apoptosis. This evidence concerns the gene RUVBL1 and lung carcinoma.